Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.91
- Piotroski Score 8.00
- Grade Buy
- Symbol (PBH)
- Company Prestige Consumer Healthcare Inc.
- Price $84.17
- Changes Percentage (1.81%)
- Change $1.5
- Day Low $82.67
- Day High $84.26
- Year High $84.26
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
- Last Earnings N/A
- Ex-Dividend for 5/16 Dividend 09/27/2018
- Dividend Payable 10/15/2018
- Today N/A
- Next Earnings (Estimated) 02/06/2025
- Fiscal Year End N/A
- Average Stock Price Target $89.50
- High Stock Price Target $93.00
- Low Stock Price Target $86.00
- Potential Upside/Downside N/A
- Consensus Rating Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $4.17
- Trailing P/E Ratio 15.69
- Forward P/E Ratio 15.69
- P/E Growth 15.69
- Net Income $209.34 M
Income Statement
Quarterly
Annual
Latest News of PBH
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Retail investors in Pathfinder Bancorp, Inc. (NASDAQ:PBHC) are its biggest bettors, and their bets paid off as stock gained 18% last week
Pathfinder Bancorp has 7 investors owning a majority stake of 50%, with retail investors holding the largest share at 30%. The company's market cap hit US$100m with a 18% stock gain....
By Yahoo! Finance | 1 month ago -
Pathfinder Bancorp, Inc. (NASDAQ:PBHC) Looks Interesting, And It's About To Pay A Dividend
Pathfinder Bancorp, Inc. (NASDAQ:PBHC) is set to trade ex-dividend soon, with a dividend payment of US$0.10 per share. The company shows promising dividend growth, making it worth investigating for po...
By Yahoo! Finance | 4 months ago -
A Closer Look At Premium Brands Holdings Corporation's (TSE:PBH) Uninspiring ROE
Return on Equity (ROE) measures a company's ability to generate profit from shareholder's equity. Premium Brands Holdings has a ROE of 5.4%, lower than the industry average of 9.1%....
By Yahoo! Finance | 4 months ago
